168 related articles for article (PubMed ID: 12185956)
1. Preclinical testing for teratogenicity and developmental toxicity: methods and limitations.
Barrow PC
Therapie; 2002; 57(2):109-14. PubMed ID: 12185956
[TBL] [Abstract][Full Text] [Related]
2. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
EFSA GMO Panel Working Group on Animal Feeding Trials
Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the nonsteroidal anti-inflammatory drug literature for potential developmental toxicity in rats and rabbits.
Cook JC; Jacobson CF; Gao F; Tassinari MS; Hurtt ME; DeSesso JM
Birth Defects Res B Dev Reprod Toxicol; 2003 Feb; 68(1):5-26. PubMed ID: 12852480
[TBL] [Abstract][Full Text] [Related]
4. The use of human cell line reporter gene-based assays in chemical toxicity testing.
Scrivens M; Bhogal N
Toxicol In Vitro; 2007 Oct; 21(7):1233-40. PubMed ID: 17604594
[TBL] [Abstract][Full Text] [Related]
5. Prediction of risk for human developmental toxicity: how important are animal studies for hazard identification?
Jelovsek FR; Mattison DR; Chen JJ
Obstet Gynecol; 1989 Oct; 74(4):624-36. PubMed ID: 2797639
[TBL] [Abstract][Full Text] [Related]
6. [Toxicology animal studies necessary for clinical research and registration of drugs for human use: conclusions of the International Harmonization Conference (I)].
Rubio Terrés C; Duque I; Tristán C; Galende I
Med Clin (Barc); 1993 Nov; 101(18):705-16. PubMed ID: 8114529
[No Abstract] [Full Text] [Related]
7. Utilization of animal studies to determine the effects and human risks of environmental toxicants (drugs, chemicals, and physical agents).
Brent RL
Pediatrics; 2004 Apr; 113(4 Suppl):984-95. PubMed ID: 15060191
[TBL] [Abstract][Full Text] [Related]
8. Preclinical formulations for discovery and toxicology: physicochemical challenges.
Neervannan S
Expert Opin Drug Metab Toxicol; 2006 Oct; 2(5):715-31. PubMed ID: 17014391
[TBL] [Abstract][Full Text] [Related]
9. Utilization of juvenile animal studies to determine the human effects and risks of environmental toxicants during postnatal developmental stages.
Brent RL
Birth Defects Res B Dev Reprod Toxicol; 2004 Oct; 71(5):303-20. PubMed ID: 15505806
[TBL] [Abstract][Full Text] [Related]
10. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
11. Relation of preclinical toxicology to findings in early clinical trials.
Grieshaber CK; Marsoni S
Cancer Treat Rep; 1986 Jan; 70(1):65-72. PubMed ID: 3943115
[TBL] [Abstract][Full Text] [Related]
12. Do preclinical testing strategies help predict human hepatotoxic potentials?
Peters TS
Toxicol Pathol; 2005; 33(1):146-54. PubMed ID: 15805066
[TBL] [Abstract][Full Text] [Related]
13. Juvenile animal toxicity study designs to support pediatric drug development.
Cappon GD; Bailey GP; Buschmann J; Feuston MH; Fisher JE; Hew KW; Hoberman AM; Ooshima Y; Stump DG; Hurtt ME
Birth Defects Res B Dev Reprod Toxicol; 2009 Dec; 86(6):463-9. PubMed ID: 20025047
[TBL] [Abstract][Full Text] [Related]
14. Healthy animals and animal models of human disease(s) in safety assessment of human pharmaceuticals, including therapeutic antibodies.
Dixit R; Boelsterli UA
Drug Discov Today; 2007 Apr; 12(7-8):336-42. PubMed ID: 17395094
[TBL] [Abstract][Full Text] [Related]
15. Preclinical predictors of clinical safety: opportunities for improvement.
Sistare FD; DeGeorge JJ
Clin Pharmacol Ther; 2007 Aug; 82(2):210-4. PubMed ID: 17507920
[TBL] [Abstract][Full Text] [Related]
16. Determination of genetic toxicity and potential carcinogenicity in vitro--challenges post the Seventh Amendment to the European Cosmetics Directive.
Tweats DJ; Scott AD; Westmoreland C; Carmichael PL
Mutagenesis; 2007 Jan; 22(1):5-13. PubMed ID: 17142828
[TBL] [Abstract][Full Text] [Related]
17. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
[TBL] [Abstract][Full Text] [Related]
18. An overview of developmental and reproductive toxicity risk assessment in China.
Wang H; Wang Q; Liao M
Birth Defects Res B Dev Reprod Toxicol; 2010 Feb; 89(1):2-8. PubMed ID: 20077514
[TBL] [Abstract][Full Text] [Related]
19. A tier system for developmental toxicity evaluations based on considerations of exposure and effect relationships.
Johnson EM
Teratology; 1987 Jun; 35(3):405-27. PubMed ID: 3307013
[TBL] [Abstract][Full Text] [Related]
20. Strengths and limitations of using repeat-dose toxicity studies to predict effects on fertility.
Dent MP
Regul Toxicol Pharmacol; 2007 Aug; 48(3):241-58. PubMed ID: 17512650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
